Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 5th edition, 486 pages

Free download

  Colorectal Neoplasms

  Free Subscription


1 Ann Oncol
4 Anticancer Res
4 BMC Cancer
1 BMC Gastroenterol
1 Cancer
14 Dis Colon Rectum
5 Eur J Surg Oncol
4 Hum Pathol
1 Int J Cancer
2 Int J Colorectal Dis
1 J Surg Oncol
4 Oncol Rep
1 PLoS One
1 Proc Natl Acad Sci U S A
1 World J Surg

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Oncol

  1. YAMAZAKI K, Yamanaka T, Shiozawa M, Manaka D, et al
    Oxaliplatin-Based Adjuvant Chemotherapy Duration (3 vs. 6 Months) for High-Risk Stage II Colon Cancer: The Randomized Phase 3 ACHIEVE-2 Trial.
    Ann Oncol. 2020 Oct 26. pii: S0923-7534(20)42983.
    PubMed         Abstract available

    Anticancer Res

  2. MUSA M, Ouaret D, Bodmer WF
    In Vitro Analyses of Interactions Between Colonic Myofibroblasts and Colorectal Cancer Cells for Anticancer Study.
    Anticancer Res. 2020;40:6063-6073.
    PubMed         Abstract available

  3. AHMED A, Halama N
    Tertiary Lymphoid Structures in Colorectal Cancer Liver Metastases: Association With Immunological and Clinical Parameters and Chemotherapy Response.
    Anticancer Res. 2020;40:6367-6373.
    PubMed         Abstract available

  4. NGAMKHAM J, Thuwajit C, Thuwajit P, Khamwachirapithak P, et al
    Overexpression of Pyruvate Carboxylase Is Correlated With Colorectal Cancer Progression and Supports Growth of Invasive Colon Cancer HT-29 Cell Line.
    Anticancer Res. 2020;40:6285-6293.
    PubMed         Abstract available

  5. LIN PM, Lee HM, Huang CI, Tai TS, et al
    Synergistic Antiproliferative Effect of Ribociclib (LEE011) and 5-Fluorouracil on Human Colorectal Cancer.
    Anticancer Res. 2020;40:6265-6271.
    PubMed         Abstract available

    BMC Cancer

  6. DAU H, Safari A, Saad El Din K, McTaggart-Cowan H, et al
    Assessing how health information needs of individuals with colorectal cancer are met across the care continuum: an international cross-sectional survey.
    BMC Cancer. 2020;20:1031.
    PubMed         Abstract available

  7. PRESTON JL, Stiffler N
    Epigenetic loss of heterozygosity of Apc and an inflammation-associated mutational signature detected in Lrig1(+/-)-driven murine colonic adenomas.
    BMC Cancer. 2020;20:126.
    PubMed         Abstract available

  8. NOWAK RG, Nnaji CH, Dauda W, Mitchell A, et al
    Satisfaction with high-resolution anoscopy for anal cancer screening among men who have sex with men: a cross-sectional survey in Abuja, Nigeria.
    BMC Cancer. 2020;20:98.
    PubMed         Abstract available

  9. ARNOLD A, Tronser M, Sers C, Ahadova A, et al
    The majority of beta-catenin mutations in colorectal cancer is homozygous.
    BMC Cancer. 2020;20:1038.
    PubMed         Abstract available

    BMC Gastroenterol

  10. ATAKA R, Tanaka H, Yagi S, Yamane K, et al
    Eosinophilic peritonitis with colon cancer: a case report.
    BMC Gastroenterol. 2020;20:353.
    PubMed         Abstract available


  11. ZAHND WE, Gomez SL, Steck SE, Brown MJ, et al
    Rural-urban and racial/ethnic trends and disparities in early-onset and average-onset colorectal cancer.
    Cancer. 2020 Oct 28. doi: 10.1002/cncr.33256.
    PubMed         Abstract available

    Dis Colon Rectum

  12. PATEL SV, Ko G, Raphael MJ, Booth CM, et al
    Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma: Use, Risk Factors, and Outcomes in a Canadian Population.
    Dis Colon Rectum. 2020;63:748-757.
    PubMed         Abstract available

  13. MATSUDA T, Yamashita K, Hasegawa H, Arimoto A, et al
    Reliable Dissection Technique During Transanal Total Mesorectal Excision Using a Lateral-First Approach.
    Dis Colon Rectum. 2020;63:859.

  14. MAKARAINEN-UHLBACK EJ, Klintrup KHB, Vierimaa MT, Carpelan-Holmstrom MA, et al
    Prospective, Randomized Study on the Use of Prosthetic Mesh to Prevent a Parastomal Hernia in a Permanent Colostomy: Results of a Long-term Follow-up.
    Dis Colon Rectum. 2020;63:678-684.
    PubMed         Abstract available

  15. KVERNENG HULTBERG D, Svensson J, Jutesten H, Rutegard J, et al
    The Impact of Anastomotic Leakage on Long-term Function After Anterior Resection for Rectal Cancer.
    Dis Colon Rectum. 2020;63:619-628.
    PubMed         Abstract available

  16. COUWENBERG AM, Intven MPW, Gregorowitsch ML, Haaring C, et al
    Patient-Reported Work Ability During the First Two Years After Rectal Cancer Diagnosis.
    Dis Colon Rectum. 2020;63:578-587.
    PubMed         Abstract available

  17. Predictors for Anastomotic Leak, Postoperative Complications, and Mortality After Right Colectomy for Cancer: Results From an International Snapshot Audit.
    Dis Colon Rectum. 2020;63:606-618.
    PubMed         Abstract available

  18. HUPKENS BJP, Breukink SO, Stoot JHMB, Toebes RE, et al
    Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
    Dis Colon Rectum. 2020;63:598-605.
    PubMed         Abstract available

  19. CRIPPA J, Duchalais E, Machairas N, Merchea A, et al
    Long-term Oncological Outcomes Following Anastomotic Leak in Rectal Cancer Surgery.
    Dis Colon Rectum. 2020;63:769-777.
    PubMed         Abstract available

  20. WIDMAR M, Aggarwal P, Keskin M, Strombom PD, et al
    Intracorporeal Anastomoses in Minimally Invasive Right Colectomies Are Associated With Fewer Incisional Hernias and Shorter Length of Stay.
    Dis Colon Rectum. 2020;63:685-692.
    PubMed         Abstract available

  21. HUANG B, Gao W, Zhu Z, Li D, et al
    Congress Report from the Shanghai Lujiazui International Colorectal Week 2019.
    Dis Colon Rectum. 2020;63:569-572.

  22. KIM JM, Park JW, Lee JH, Park YH, et al
    Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer.
    Dis Colon Rectum. 2020;63:758-768.
    PubMed         Abstract available

  23. OKADA T, Kawada K, Sumii A, Itatani Y, et al
    Stereotactic Navigation for Rectal Surgery: Comparison of 3-Dimensional C-Arm-Based Registration to Paired-Point Registration.
    Dis Colon Rectum. 2020;63:693-700.
    PubMed         Abstract available

  24. SAPCI I, Gorgun E
    Removal of a Large Rectal Lesion With Endoscopic Submucosal Dissection Using a New Endolumenal Platform.
    Dis Colon Rectum. 2020;63:710.

  25. MIREIA MR, Carlos CS
    Anal Melanoma: A Rare Perianal Tumor With a Poor Prognosis.
    Dis Colon Rectum. 2020;63:573-576.
    PubMed         Abstract available

    Eur J Surg Oncol

  26. D'HONDT M, Willems E, Parmentier I, Pottel H, et al
    Laparoscopic liver resection for liver tumours in proximity to major vasculature: A single-center comparative study.
    Eur J Surg Oncol. 2020;46.
    PubMed         Abstract available

  27. BHATT A, Yonemura Y, Mehta S, Benzerdjeb N, et al
    Target region resection in patients undergoing cytoreductive surgery for peritoneal metastases-is it necessary in absence of visible disease?
    Eur J Surg Oncol. 2020;46.
    PubMed         Abstract available

  28. HENTZEN JEKR, van der Plas WY, Kuipers H, Ramcharan S, et al
    Delta peritoneal cancer index (DeltaPCI): A new dynamic prognostic parameter for survival in patients with colorectal peritoneal metastases.
    Eur J Surg Oncol. 2020;46.
    PubMed         Abstract available

  29. KLOS D, Risko J, Krivackova D, Lovecek M, et al
    Cost analysis of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and the risk factors for their increased cost in a public insurance health care system - Single centre study.
    Eur J Surg Oncol. 2020;46.
    PubMed         Abstract available

  30. SOMASHEKHAR SP, Yethadka R, Kumar C R, Ashwin KR, et al
    Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
    Eur J Surg Oncol. 2020;46.
    PubMed         Abstract available

    Hum Pathol

  31. GUI X, Iacucci M, Ghosh S, Ferraz JGP, et al
    Revisiting the Distinct Histomorphologic Features of Inflammatory Bowel Disease -Associated Neoplastic Precursor Lesions in SCENIC and Post-DALM Era.
    Hum Pathol. 2020 May 5. pii: S0046-8177(20)30083.
    PubMed         Abstract available

  32. VILLATORO TM, Ma C, Pai RK
    Switch/sucrose nonfermenting nucleosome complex-deficient colorectal carcinomas have distinct clinicopathologic features.
    Hum Pathol. 2020;99:53-61.
    PubMed         Abstract available

  33. LIN MT, Zheng G, Tseng LH, Zhang P, et al
    Multiclonal colorectal cancers with divergent histomorphological features and RAS mutations: one cancer or separate cancers?
    Hum Pathol. 2020;98:120-128.
    PubMed         Abstract available

  34. MILLER GC, Liu C, Bettington ML, Leggett B, et al
    Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease.
    Hum Pathol. 2020 Jan 6. pii: S0046-8177(19)30234.
    PubMed         Abstract available

    Int J Cancer

  35. THURMAIER J, Heinemann V, Engel J, Schubert-Fritschle G, et al
    Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival.
    Int J Cancer. 2020 Oct 28. doi: 10.1002/ijc.33364.
    PubMed         Abstract available

    Int J Colorectal Dis

  36. ZHANG X, Zhang Y, Wei M, Wang M, et al
    Letter to the editor regarding "Does adding lateral pelvic lymph node dissection to neoadjuvant chemotherapy improve outcomes in low rectal cancer?"
    Int J Colorectal Dis. 2020;35:2139-2140.

  37. TIAN Y, Rong L, Ma Y
    Surgical resection after endoscopic resection in patients with T1 colorectal cancer: a meta-analysis.
    Int J Colorectal Dis. 2020 Oct 27. pii: 10.1007/s00384-020-03752.
    PubMed         Abstract available

    J Surg Oncol

  38. ALESE OB, Zakka K, Huo X, Jiang R, et al
    Perioperative therapy in metastatic colorectal cancer: Pattern of use and survival outcomes.
    J Surg Oncol. 2020 Oct 30. doi: 10.1002/jso.26278.
    PubMed         Abstract available

    Oncol Rep

  39. ZHANG XW, Li SL, Zhang D, Sun XL, et al
    RP11619L19.2 promotes colon cancer development by regulating the miR12715p/CD164 axis.
    Oncol Rep. 2020 Oct 7. doi: 10.3892/or.2020.7794.
    PubMed         Abstract available

  40. CHIANG JH, Tsai FJ, Hsu YM, Yin MC, et al
    Sensitivity of allyl isothiocyanate to induce apoptosis via ER stress and the mitochondrial pathway upon ROS production in colorectal adenocarcinoma cells.
    Oncol Rep. 2020;44:1415-1424.
    PubMed         Abstract available

  41. HE J, Zhao H, Liu X, Wang D, et al
    Sevoflurane suppresses cell viability and invasion and promotes cell apoptosis in colon cancer by modulating exosomemediated circHMGCS1 via the miR34a5p/SGPP1 axis.
    Oncol Rep. 2020 Sep 29. doi: 10.3892/or.2020.7783.
    PubMed         Abstract available

  42. WANG G, Yu Y, Wang YZ, Zhu ZM, et al
    Effects and mechanisms of fatty acid metabolismmediated glycolysis regulated by betulinic acidloaded nanoliposomes in colorectal cancer.
    Oncol Rep. 2020 Oct 1. doi: 10.3892/or.2020.7787.
    PubMed         Abstract available

    PLoS One

  43. ZHANG T, Ahn K, Emerick B, Modarai SR, et al
    APC mutations in human colon lead to decreased neuroendocrine maturation of ALDH+ stem cells that alters GLP-2 and SST feedback signaling: Clue to a link between WNT and retinoic acid signalling in colon cancer development.
    PLoS One. 2020;15:e0239601.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  44. BRYAN DS, Stack M, Krysztofiak K, Cichon U, et al
    4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasis.
    Proc Natl Acad Sci U S A. 2020;117:22423-22429.
    PubMed         Abstract available

    World J Surg

  45. WATANABE G, Mise Y, Ito H, Inoue Y, et al
    Repeat Hepatectomy for Early Recurrence of Colorectal Liver Metastases-Prognostic Impacts Assessed from the Recurrence Pattern.
    World J Surg. 2020;44:268-276.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.